229 related articles for article (PubMed ID: 28541119)
1. Treatment of opioid use disorder with ibogaine: detoxification and drug use outcomes.
Brown TK; Alper K
Am J Drug Alcohol Abuse; 2018; 44(1):24-36. PubMed ID: 28541119
[TBL] [Abstract][Full Text] [Related]
2. Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study.
Noller GE; Frampton CM; Yazar-Klosinski B
Am J Drug Alcohol Abuse; 2018; 44(1):37-46. PubMed ID: 28402682
[TBL] [Abstract][Full Text] [Related]
3. Changes in Withdrawal and Craving Scores in Participants Undergoing Opioid Detoxification Utilizing Ibogaine.
Malcolm BJ; Polanco M; Barsuglia JP
J Psychoactive Drugs; 2018; 50(3):256-265. PubMed ID: 29608409
[TBL] [Abstract][Full Text] [Related]
4. Treatment of acute opioid withdrawal with ibogaine.
Alper KR; Lotsof HS; Frenken GM; Luciano DJ; Bastiaans J
Am J Addict; 1999; 8(3):234-42. PubMed ID: 10506904
[TBL] [Abstract][Full Text] [Related]
5. The ibogaine medical subculture.
Alper KR; Lotsof HS; Kaplan CD
J Ethnopharmacol; 2008 Jan; 115(1):9-24. PubMed ID: 18029124
[TBL] [Abstract][Full Text] [Related]
6. A Mixed-Method Analysis of Persisting Effects Associated with Positive Outcomes Following Ibogaine Detoxification.
Davis AK; Renn E; Windham-Herman AM; Polanco M; Barsuglia JP
J Psychoactive Drugs; 2018; 50(4):287-297. PubMed ID: 30020025
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the toxicity and therapeutic potential of ibogaine in the treatment of chronic opioid abuse.
Luz M; Mash DC
Expert Opin Drug Metab Toxicol; 2021 Sep; 17(9):1019-1022. PubMed ID: 34139922
[No Abstract] [Full Text] [Related]
8. The pharmacokinetics and pharmacodynamics of ibogaine in opioid use disorder patients.
Knuijver T; Ter Heine R; Schellekens AFA; Heydari P; Lucas L; Westra S; Belgers M; van Oosteren T; Verkes RJ; Kramers C
J Psychopharmacol; 2024 May; 38(5):481-488. PubMed ID: 38519421
[TBL] [Abstract][Full Text] [Related]
9. Remission of Severe Opioid Use Disorder with Ibogaine: A Case Report.
Cloutier-Gill L; Wood E; Millar T; Ferris C; Eugenia Socias M
J Psychoactive Drugs; 2016; 48(3):214-7. PubMed ID: 27192438
[TBL] [Abstract][Full Text] [Related]
10. Safety of ibogaine administration in detoxification of opioid-dependent individuals: a descriptive open-label observational study.
Knuijver T; Schellekens A; Belgers M; Donders R; van Oosteren T; Kramers K; Verkes R
Addiction; 2022 Jan; 117(1):118-128. PubMed ID: 33620733
[TBL] [Abstract][Full Text] [Related]
11. IUPHAR - invited review - Ibogaine - A legacy within the current renaissance of psychedelic therapy.
Mash DC
Pharmacol Res; 2023 Apr; 190():106620. PubMed ID: 36907284
[TBL] [Abstract][Full Text] [Related]
12. Effect of Iboga alkaloids on µ-opioid receptor-coupled G protein activation.
Antonio T; Childers SR; Rothman RB; Dersch CM; King C; Kuehne M; Bornmann WG; Eshleman AJ; Janowsky A; Simon ER; Reith ME; Alper K
PLoS One; 2013; 8(10):e77262. PubMed ID: 24204784
[TBL] [Abstract][Full Text] [Related]
13. Ascending Single-Dose, Double-Blind, Placebo-Controlled Safety Study of Noribogaine in Opioid-Dependent Patients.
Glue P; Cape G; Tunnicliff D; Lockhart M; Lam F; Hung N; Hung CT; Harland S; Devane J; Crockett RS; Howes J; Darpo B; Zhou M; Weis H; Friedhoff L
Clin Pharmacol Drug Dev; 2016 Nov; 5(6):460-468. PubMed ID: 27870477
[TBL] [Abstract][Full Text] [Related]
14. Ibogaine Detoxification Transitions Opioid and Cocaine Abusers Between Dependence and Abstinence: Clinical Observations and Treatment Outcomes.
Mash DC; Duque L; Page B; Allen-Ferdinand K
Front Pharmacol; 2018; 9():529. PubMed ID: 29922156
[TBL] [Abstract][Full Text] [Related]
15. Treating drug dependence with the aid of ibogaine: a retrospective study.
Schenberg EE; de Castro Comis MA; Chaves BR; da Silveira DX
J Psychopharmacol; 2014 Nov; 28(11):993-1000. PubMed ID: 25271214
[TBL] [Abstract][Full Text] [Related]
16. A preliminary investigation of ibogaine: case reports and recommendations for further study.
Sheppard SG
J Subst Abuse Treat; 1994; 11(4):379-85. PubMed ID: 7966509
[TBL] [Abstract][Full Text] [Related]
17. Ibogaine as a treatment for substance misuse: Potential benefits and practical dangers.
Corkery JM
Prog Brain Res; 2018; 242():217-257. PubMed ID: 30471681
[TBL] [Abstract][Full Text] [Related]
18. Ibogaine: complex pharmacokinetics, concerns for safety, and preliminary efficacy measures.
Mash DC; Kovera CA; Pablo J; Tyndale RF; Ervin FD; Williams IC; Singleton EG; Mayor M
Ann N Y Acad Sci; 2000 Sep; 914():394-401. PubMed ID: 11085338
[TBL] [Abstract][Full Text] [Related]
19. Fatalities temporally associated with the ingestion of ibogaine.
Alper KR; Stajić M; Gill JR
J Forensic Sci; 2012 Mar; 57(2):398-412. PubMed ID: 22268458
[TBL] [Abstract][Full Text] [Related]
20. Ibogaine Consumption With Seizure-Like Episodes, QTc-Prolongation, and Captured Cardiac Dysrhythmias.
Grogan J; Gerona R; Snow JW; Kao L
J Emerg Med; 2019 Oct; 57(4):e99-e104. PubMed ID: 31630892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
